Michelson Diagnostics diversifies into non-medical markets

October 3, 2008: Reacting to strong customer demand, Michelson Diagnostics Ltd. (MDL) is broadening the commercial application of its ‘multibeam’ optical coherence tomography (OCT) technology into markets outside its core target of cancer diagnosis, such as industrial metrology, product inspection, tissue engineering, and developmental biology.

“We are reacting to customers who have realised that the superior image definition provided by our patented multi-beam OCT technology is advantageous in their applications”, said MDL CEO Jon Holmes, in a statement. “For a given depth-of-focus, you get twice the resolution, (or, for a given resolution, four times the focal depth), compared with single beam OCT systems — which means crisper, clearer images.”

He cited applications such as MEMS metrology, inspection of ceramic composite materials and industrial coatings, fine art conservation, gemstone quality, stem cell research, and dentistry as examples.

The company currently markets the EX1301 OCT microscope with <10μm lateral resolution, by virtue of its multi-beam optical design.

EX1301 OCT microscope in use.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.